CXCR4: A virus's best friend?

Infection, Genetics and Evolution

Volumn 25, Issue , 2014, Pages 146-156

  Arnolds, Kathleen L ^a   Spencer, Juliet V ^a  

^a UNIVERSITY OF SAN FRANCISCO   (United States)

Author keywords

Chemokine receptor; CXCL12; CXCR4; GPCR; Stromal derived factor; Trafficking

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; STROMAL CELL DERIVED FACTOR 1; DNA VIRUS;

CHIKUNGUNYA ALPHAVIRUS; EPSTEIN BARR VIRUS; EVOLUTION; HERPES SIMPLEX VIRUS 1; HUMAN CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 6; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNE RESPONSE; MOLLUSCIPOXVIRUS; MYXOMA VIRUS; NONHUMAN; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; VIRUS VIRULENCE; CELL SURVIVAL; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; METABOLISM; RETROVIRUS;

CELL SURVIVAL; CHEMOKINE CXCL12; DNA VIRUSES; HOST-PATHOGEN INTERACTIONS; HUMANS; RECEPTORS, CXCR4; RETROVIRIDAE; SIGNAL TRANSDUCTION;

EID: 84900794468     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2014.04.018     Document Type: Review

References (124)

1. Ahmed S.M., Angers S. Emerging non-canonical functions for heterotrimeric G proteins in cellular signaling. J. Recept. Signal Transduct. Res. 2013, 33:177-183.
2. Amine A., Rivera S., Opolon P., Dekkal M., Biard D.S., Bouamar H., Louache F., McKay M.J., Bourhis J., Deutsch E., Vozenin-Brotons M.C. Novel anti-metastatic action of cidofovir mediated by inhibition of E6/E7, CXCR4 and Rho/ROCK signaling in HPV tumor cells. PloS ONE 2009, 4:e5018.
3. Appay V., Rowland-Jones S.L. RANTES: a versatile and controversial chemokine. Trends Immunol. 2001, 22:83-87.
4. Arai M., Ohashi T., Tsukahara T., Murakami T., Hori T., Uchiyama T., Yamamoto N., Kannagi M., Fujii M. Human T-cell leukemia virus type 1 Tax protein induces the expression of lymphocyte chemoattractant SDF-1/PBSF. Virology 1998, 241:298-303.
5. Arnolds K.L., Lares A.P., Spencer J.V. The US27 gene product of human cytomegalovirus enhances signaling of host chemokine receptor CXCR4. Virology 2013, 439:122-131.
6. Asada H., Klaus-Kovtun V., Golding H., Katz S.I., Blauvelt A. Human herpesvirus 6 infects dendritic cells and suppresses human immunodeficiency virus type 1 replication in coinfected cultures. J. Virol. 1999, 73:4019-4028.
7. Babcock G.J., Farzan M., Sodroski J. Ligand-independent dimerization of CXCR4, a principal HIV-1 coreceptor. J. Biol. Chem. 2003, 278:3378-3385.
8. Balabanian K., Lagane B., Infantino S., Chow K.Y., Harriague J., Moepps B., Arenzana-Seisdedos F., Thelen M., Bachelerie F. The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J. Biol. Chem. 2005, 280:35760-35766.
9. Baltus T., von Hundelshausen P., Mause S.F., Buhre W., Rossaint R., Weber C. Differential and additive effects of platelet-derived chemokines on monocyte arrest on inflamed endothelium under flow conditions. J. Leukoc. Biol. 2005, 78:435-441.
10. Beisser P.S., Verzijl D., Gruijthuijsen Y.K., Beuken E., Smit M.J., Leurs R., Bruggeman C.A., Vink C. The Epstein-Barr virus BILF1 gene encodes a G protein-coupled receptor that inhibits phosphorylation of RNA-dependent protein kinase. J. Virol. 2005, 79:441-449.
11. Ben-Baruch A. Site-specific metastasis formation: chemokines as regulators of tumor cell adhesion, motility and invasion. Cell Adhes. Migr. 2009, 3:328-333.
12. Berson J.F., Long D., Doranz B.J., Rucker J., Jirik F.R., Doms R.W. A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains. J. Virol. 1996, 70:6288-6295.
13. Billstrom M.A., Johnson G.L., Avdi N.J., Worthen G.S. Intracellular signaling by the chemokine receptor US28 during human cytomegalovirus infection. J. Virol. 1998, 72:5535-5544.
14. Blanco J., Barretina J., Henson G., Bridger G., De Clercq E., Clotet B., Este J.A. The CXCR4 antagonist AMD3100 efficiently inhibits cell-surface-expressed human immunodeficiency virus type 1 envelope-induced apoptosis. Antimicrob. Agents Chemother. 2000, 44:51-56.
15. Bleul C.C., Fuhlbrigge R.C., Casasnovas J.M., Aiuti A., Springer T.A. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J. Exp. Med. 1996, 184:1101-1109.
16. Bleul C.C., Schultze J.L., Springer T.A. B lymphocyte chemotaxis regulated in association with microanatomic localization, differentiation state, and B cell receptor engagement. J. Exp. Med. 1998, 187:753-762.
17. Bleul C.C., Wu L., Hoxie J.A., Springer T.A., Mackay C.R. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:1925-1930.
18. Bodaghi B., Jones T.R., Zipeto D., Vita C., Sun L., Laurent L., Arenzana-Seisdedos F., Virelizier J.L., Michelson S. Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy: withdrawal of chemokines from the environment of cytomegalovirus-infected cells. J. Exp. Med. 1998, 188:855-866.
19. Boularan C., Kehrl J.H. Implications of non-canonical G-protein signaling for the immune system. Cell. Signal. 2014, 26:1269-1282.
20. Boxus M., Twizere J.C., Legros S., Dewulf J.F., Kettmann R., Willems L. The HTLV-1 Tax interactome. Retrovirology 2008, 5:76.
21. Braun D.K., Dominguez G., Pellett P.E. Human herpesvirus 6. Clin. Microbiol. Rev. 1997, 10:521-567.
22. Burns J.M., Summers B.C., Wang Y., Melikian A., Berahovich R., Miao Z., Penfold M.E., Sunshine M.J., Littman D.R., Kuo C.J., Wei K., McMaster B.E., Wright K., Howard M.C., Schall T.J. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J. Exp. Med. 2006, 203:2201-2213.
23. Busillo J.M., Benovic J.L. Regulation of CXCR4 signaling. Biochim. Biophys. Acta 2007, 1768:952-963.
24. Carrigan D.R., Knox K.K., Tapper M.A. Suppression of human immunodeficiency virus type 1 replication by human herpesvirus-6. J. Infect. Dis. 1990, 162:844-851.
25. Charo I.F., Ransohoff R.M. The many roles of chemokines and chemokine receptors in inflammation. N. Engl. J. Med. 2006, 354:610-621.
26. Chow K.Y., Brotin E., Ben Khalifa Y., Carthagena L., Teissier S., Danckaert A., Galzi J.L., Arenzana-Seisdedos F., Thierry F., Bachelerie F. A pivotal role for CXCL12 signaling in HPV-mediated transformation of keratinocytes: clues to understanding HPV-pathogenesis in WHIM syndrome. Cell Host Microbe 2010, 8:523-533.
27. Ciesielska U., Nowinska K., Podhorska-Okolow M., Dziegiel P. The role of human papillomavirus in the malignant transformation of cervix epithelial cells and the importance of vaccination against this virus. Adv. Clin. Exp. Med. 2012, 21:235-244.
28. Cloyd M.W., Moore B.E. Spectrum of biological properties of human immunodeficiency virus (HIV-1) isolates. Virology 1990, 174:103-116.
29. Cronin P.A., Wang J.H., Redmond H.P. Hypoxia increases the metastatic ability of breast cancer cells via upregulation of CXCR4. BMC Cancer 2010, 10:225.
30. De Clercq E. The AMD3100 story: the path to the discovery of a stem cell mobilizer (Mozobil). Biochem. Pharmacol. 2009, 77:1655-1664.
31. DeVries M.E., Kelvin A.A., Xu L., Ran L., Robinson J., Kelvin D.J. Defining the origins and evolution of the chemokine/chemokine receptor system. J. Immunol. 2006, 176:401-415.
32. Doms R.W., Trono D. The plasma membrane as a combat zone in the HIV battlefield. Genes Dev. 2000, 14:2677-2688.
33. Drake M.T., Shenoy S.K., Lefkowitz R.J. Trafficking of G protein-coupled receptors. Circ. Res. 2006, 99:570-582.
34. Dunn W., Chou C., Li H., Hai R., Patterson D., Stolc V., Zhu H., Liu F. Functional profiling of a human cytomegalovirus genome. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:14223-14228.
35. Ehlin-Henriksson B., Mowafi F., Klein G., Nilsson A. Epstein-Barr virus infection negatively impacts the CXCR4-dependent migration of tonsillar B cells. Immunology 2006, 117:379-385.
36. Ensoli B., Lusso P., Schachter F., Josephs S.F., Rappaport J., Negro F., Gallo R.C., Wong-Staal F. Human herpes virus-6 increases HIV-1 expression in co-infected T cells via nuclear factors binding to the HIV-1 enhancer. EMBO J. 1989, 8:3019-3027.
37. Farzan M., Mirzabekov T., Kolchinsky P., Wyatt R., Cayabyab M., Gerard N.P., Gerard C., Sodroski J., Choe H. Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry. Cell 1999, 96:667-676.
38. Feng Y., Broder C.C., Kennedy P.E., Berger E.A. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996, 272:872-877.
39. Frascaroli G., Varani S., Blankenhorn N., Pretsch R., Bacher M., Leng L., Bucala R., Landini M.P., Mertens T. Human cytomegalovirus paralyzes macrophage motility through down-regulation of chemokine receptors, reorganization of the cytoskeleton, and release of macrophage migration inhibitory factor. J. Immunol. 2009, 182:477-488.
40. Greene W.C., Peterlin B.M. Charting HIV's remarkable voyage through the cell: basic science as a passport to future therapy. Nat. Med. 2002, 8:673-680.
41. Gupta S.K., Lysko P.G., Pillarisetti K., Ohlstein E., Stadel J.M. Chemokine receptors in human endothelial cells. Functional expression of CXCR4 and its transcriptional regulation by inflammatory cytokines. J. Biol. Chem. 1998, 273:4282-4287.
42. Gupta S.K., Pillarisetti K., Lysko P.G. Modulation of CXCR4 expression and SDF-1alpha functional activity during differentiation of human monocytes and macrophages. J. Leukoc. Biol. 1999, 66:135-143.
43. Gustin J.K., Moses A.V., Fruh K., Douglas J.L. Viral takeover of the host ubiquitin system. Front. Microbiol. 2011, 2:161.
44. Hajishengallis G., Wang M., Liang S., Triantafilou M., Triantafilou K. Pathogen induction of CXCR4/TLR2 cross-talk impairs host defense function. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:13532-13537.
45. Hasegawa A., Yasukawa M., Sakai I., Fujita S. Transcriptional down-regulation of CXC chemokine receptor 4 induced by impaired association of transcription regulator YY1 with c-Myc in human herpesvirus 6-infected cells. J. Immunol. 2001, 166:1125-1131.
46. Hendrix C.W., Flexner C., MacFarland R.T., Giandomenico C., Fuchs E.J., Redpath E., Bridger G., Henson G.W. Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers. Antimicrob. Agents Chemother. 2000, 44:1667-1673.
47. Hermans E. Biochemical and pharmacological control of the multiplicity of coupling at G-protein-coupled receptors. Pharmacol. Ther. 2003, 99:25-44.
48. Hernandez P.A., Gorlin R.J., Lukens J.N., Taniuchi S., Bohinjec J., Francois F., Klotman M.E., Diaz G.A. Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nat. Genet. 2003, 34:70-74.
49. Hiller D.J., Li B.D.L., Chu Q.D. CXCR4 as a predictive marker for locally advanced breast cancer post-neoadjuvant therapy J. Surg. Res. 2011, 166:5p.
50. Hollsberg P., Hafler D.A. Seminars in medicine of the Beth Israel Hospital, Boston. Pathogenesis of diseases induced by human lymphotropic virus type I infection. N. Engl. J. Med. 1993, 328:1173-1182.
51. Holst P.J., Rosenkilde M.M. Microbiological exploitation of the chemokine system. Microbes Infect. 2003, 5:179-187.
52. Horuk R. Chemokine receptors and HIV-1: the fusion of two major research fields. Immunol. Today 1999, 20:89-94.
53. Houlihan C.F., Larke N.L., Watson-Jones D., Smith-McCune K.K., Shiboski S., Gravitt P.E., Smith J.S., Kuhn L., Wang C., Hayes R. Human papillomavirus infection and increased risk of HIV acquisition. A systematic review and meta-analysis. AIDS 2012, 26:2211-2222.
54. Howie H.L., Katzenellenbogen R.A., Galloway D.A. Papillomavirus E6 proteins. Virology 2009, 384:324-334.
55. Jin Q., Altenburg J.D., Hossain M.M., Alkhatib G. Role for the conserved N-terminal cysteines in the anti-chemokine activities by the chemokine-like protein MC148R1 encoded by Molluscum contagiosum virus. Virology 2011, 417:449-456.
56. Katritch V., Cherezov V., Stevens R.C. Diversity and modularity of G protein-coupled receptor structures. Trends Pharmacol. Sci. 2012, 33:17-27.
57. Kawaguchi A., Orba Y., Kimura T., Iha H., Ogata M., Tsuji T., Ainai A., Sata T., Okamoto T., Hall W.W., Sawa H., Hasegawa H. Inhibition of the SDF-1alpha-CXCR4 axis by the CXCR4 antagonist AMD3100 suppresses the migration of cultured cells from ATL patients and murine lymphoblastoid cells from HTLV-I Tax transgenic mice. Blood 2009, 114:2961-2968.
58. Khan S.M., Sleno R., Gora S., Zylbergold P., Laverdure J.P., Labbe J.C., Miller G.J., Hebert T.E. The expanding roles of Gbetagamma subunits in G protein-coupled receptor signaling and drug action. Pharmacol. Rev. 2013, 65:545-577.
59. Kindt, G., Osborne, 2007. Immunology. Tenney, New York.
60. Lalani A.S., Masters J., Zeng W., Barrett J., Pannu R., Everett H., Arendt C.W., McFadden G. Use of chemokine receptors by poxviruses. Science 1999, 286:1968-1971.
61. Lalani A.S., McFadden G. Evasion and exploitation of chemokines by viruses. Cytokine Growth Factor Rev. 1999, 10:219-233.
62. Lecointe D., Dugas N., Leclerc P., Hery C., Delfraissy J.F., Tardieu M. Human cytomegalovirus infection reduces surface CCR5 expression in human microglial cells, astrocytes and monocyte-derived macrophages. Microbes Infect. 2002, 4:1401-1408.
63. Levoye A., Balabanian K., Baleux F., Bachelerie F., Lagane B. CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling. Blood 2009, 113:6085-6093.
64. Levy J.A. Pathogenesis of human immunodeficiency virus infection. Microbiol. Rev. 1993, 57:183-289.
65. Liston A., McColl S. Subversion of the chemokine world by microbial pathogens. Bioessays 2003, 25:478-488.
66. Lusso P., De Maria A., Malnati M., Lori F., DeRocco S.E., Baseler M., Gallo R.C. Induction of CD4 and susceptibility to HIV-1 infection in human CD8+ T lymphocytes by human herpesvirus 6. Nature 1991, 349:533-535.
67. Lusso P., Ensoli B., Markham P.D., Ablashi D.V., Salahuddin S.Z., Tschachler E., Wong-Staal F., Gallo R.C. Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6. Nature 1989, 337:370-373.
68. Lusso P., Garzino-Demo A., Crowley R.W., Malnati M.S. Infection of gamma/delta T lymphocytes by human herpesvirus 6: transcriptional induction of CD4 and susceptibility to HIV infection. J. Exp. Med. 1995, 181:1303-1310.
69. Manicklal S., Emery V.C., Lazzarotto T., Boppana S.B., Gupta R.K. The "silent" global burden of congenital cytomegalovirus. Clin. Microbiol. Rev. 2013, 26:86-102.
70. Marchese A. Endocytic trafficking of chemokine receptors. Curr. Opin. Cell Biol. 2014, 27C:72-77.
71. McGrath K.E., Koniski A.D., Maltby K.M., McGann J.K., Palis J. Embryonic expression and function of the chemokine SDF-1 and its receptor, CXCR4. Dev. Biol. 1999, 213:442-456.
72. Mocarski E.S., Shenk T., Pass R.F. Cytomegaloviruses 2006, Lippincott-Raven Publishers, Philadelphia, PA.
73. Moore J.P., Trkola A., Dragic T. Co-receptors for HIV-1 entry. Curr. Opin. Immunol. 1997, 9:551-562.
74. Moriuchi M., Moriuchi H., Fauci A.S. HTLV type I Tax activation of the CXCR4 promoter by association with nuclear respiratory factor 1. AIDS Res. Hum. Retroviruses 1999, 15:821-827.
75. Munger K., Howley P.M. Human papillomavirus immortalization and transformation functions. Virus Res. 2002, 89:213-228.
76. Murdoch C. CXCR4: chemokine receptor extraordinaire. Immunol. Rev. 2000, 177:175-184.
77. Murphy P.M. Viral exploitation and subversion of the immune system through chemokine mimicry. Nat. Immunol. 2001, 2:116-122.
78. Nagasawa T., Hirota S., Tachibana K., Takakura N., Nishikawa S., Kitamura Y., Yoshida N., Kikutani H., Kishimoto T. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 1996, 382:635-638.
79. Nakayama T., Fujisawa R., Izawa D., Hieshima K., Takada K., Yoshie O. Human B cells immortalized with Epstein-Barr virus upregulate CCR6 and CCR10 and downregulate CXCR4 and CXCR5. J. Virol. 2002, 76:3072-3077.
80. Nijmeijer S., Leurs R., Smit M.J., Vischer H.F. The Epstein-Barr virus-encoded G protein-coupled receptor BILF1 hetero-oligomerizes with human CXCR4, scavenges Galphai proteins, and constitutively impairs CXCR4 functioning. J. Biol. Chem. 2010, 285:29632-29641.
81. Ogawa Y., Kawamura T., Matsuzawa T., Aoki R., Gee P., Yamashita A., Moriishi K., Yamasaki K., Koyanagi Y., Blauvelt A., Shimada S. Antimicrobial peptide LL-37 produced by HSV-2-infected keratinocytes enhances HIV infection of Langerhans cells. Cell Host Microbe 2013, 13:77-86.
82. Ok S., Kim S.M., Kim C., Nam D., Shim B.S., Kim S.H., Ahn K.S., Choi S.H., Ahn K.S. Emodin inhibits invasion and migration of prostate and lung cancer cells by downregulating the expression of chemokine receptor CXCR4. Immunopharmacol. Immunotoxicol. 2012, 34:768-778. 10.3109/08923973.2012.654494.
83. Paulsen S.J., Rosenkilde M.M., Eugen-Olsen J., Kledal T.N. Epstein-Barr virus-encoded BILF1 is a constitutively active G protein-coupled receptor. J. Virol. 2005, 79:536-546.
84. Pierce K.L., Premont R.T., Lefkowitz R.J. Seven-transmembrane receptors. Nat. Rev. Mol. Cell Biol. 2002, 3:639-650.
85. Pihlstrom B.L., Michalowicz B.S., Johnson N.W. Periodontal diseases. Lancet 2005, 366:1809-1820.
86. Piovan E., Tosello V., Indraccolo S., Cabrelle A., Baesso I., Trentin L., Zamarchi R., Tamamura H., Fujii N., Semenzato G., Chieco-Bianchi L., Amadori A. Chemokine receptor expression in EBV-associated lymphoproliferation in hu/SCID mice: implications for CXCL12/CXCR4 axis in lymphoma generation. Blood 2005, 105:931-939.
87. Pleskoff O., Treboute C., Brelot A., Heveker N., Seman M., Alizon M. Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry. Science 1997, 276:1874-1878.
88. Popple A., Durrant L.G., Spendlove I., Rolland P., Scott I.V., Deen S., Ramage J.M. The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer. Br. J. Cancer 2012, 106:8p.
89. Prechtel A.T., Turza N.M., Kobelt D.J., Eisemann J.I., Coffin R.S., McGrath Y., Hacker C., Ju X., Zenke M., Steinkasserer A. Infection of mature dendritic cells with herpes simplex virus type 1 dramatically reduces lymphoid chemokine-mediated migration. J. Gen. Virol. 2005, 86:1645-1657.
90. Proudfoot A.E., Handel T.M., Johnson Z., Lau E.K., LiWang P., Clark-Lewis I., Borlat F., Wells T.N., Kosco-Vilbois M.H. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:1885-1890.
91. Rajagopal S., Rajagopal K., Lefkowitz R.J. Teaching old receptors new tricks: biasing seven-transmembrane receptors. Nat. Rev. Drug Discov. 2010, 9:373-386.
92. Saini V., Marchese A., Majetschak M. CXC chemokine receptor 4 is a cell surface receptor for extracellular ubiquitin. J. Biol. Chem. 2010, 285:15566-15576.
93. Saini V., Romero J., Marchese A., Majetschak M. Ubiquitin receptor binding and signaling in primary human leukocytes. Commun. Integr. Biol. 2010, 3:608-610.
94. Salanga C.L., O'Hayre M., Handel T. Modulation of chemokine receptor activity through dimerization and crosstalk. Cell. Mol. Life Sci.: CMLS 2009, 66:1370-1386.
95. Samson M., Libert F., Doranz B.J., Rucker J., Liesnard C., Farber C.M., Saragosti S., Lapoumeroulie C., Cognaux J., Forceille C., Muyldermans G., Verhofstede C., Burtonboy G., Georges M., Imai T., Rana S., Yi Y., Smyth R.J., Collman R.G., Doms R.W., Vassart G., Parmentier M. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996, 382:722-725.
96. Saxena T., Tandon B., Sharma S., Chameettachal S., Ray P., Ray A.R., Kulshreshtha R. Combined miRNA and mRNA signature identifies key molecular players and pathways involved in chikungunya virus infection in human cells. PloS ONE 2013, 8:e79886.
97. Schappi J.M., Krbanjevic A., Rasenick M.M. Tubulin, actin and heterotrimeric G proteins: coordination of signaling and structure. Biochim. Biophys. Acta 2014, 1838:674-681.
98. Schwartz O., Albert M.L. Biology and pathogenesis of chikungunya virus. Nat. Rev. Microbiol. 2010, 8:491-500.
99. See H.B., Seeber R.M., Kocan M., Eidne K.A., Pfleger K.D. Application of G protein-coupled receptor-heteromer identification technology to monitor beta-arrestin recruitment to G protein-coupled receptor heteromers. Assay Drug Dev. Technol. 2011, 9:21-30.
100. Slinger E., Maussang D., Schreiber A., Siderius M., Rahbar A., Fraile-Ramos A., Lira S.A., Soderberg-Naucler C., Smit M.J. HCMV-encoded chemokine receptor US28 mediates proliferative signaling through the IL-6-STAT3 axis. Sci. Signal. 2010, 3:ra58.
101. Smith M.S., Bentz G.L., Alexander J.S., Yurochko A.D. Human cytomegalovirus induces monocyte differentiation and migration as a strategy for dissemination and persistence. J. Virol. 2004, 78:4444-4453.
102. Sodhi A., Montaner S., Gutkind J.S. Viral hijacking of G-protein-coupled-receptor signalling networks. Nat. Rev. Mol. Cell Biol. 2004, 5:998-1012.
103. Sohy D., Parmentier M., Springael J.Y. Allosteric transinhibition by specific antagonists in CCR2/CXCR4 heterodimers. J. Biol. Chem. 2007, 282:30062-30069.
104. Sozzani S., Luini W., Borsatti A., Polentarutti N., Zhou D., Piemonti L., D'Amico G., Power C.A., Wells T.N., Gobbi M., Allavena P., Mantovani A. Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines. J. Immunol. 1997, 159:1993-2000.
105. Szidonya L., Cserzo M., Hunyady L. Dimerization and oligomerization of G-protein-coupled receptors: debated structures with established and emerging functions. J. Endocrinol. 2008, 196:435-453.
106. Tadagaki K., Tudor D., Gbahou F., Tschische P., Waldhoer M., Bomsel M., Jockers R., Kamal M. Human cytomegalovirus-encoded UL33 and UL78 heteromerize with host CCR5 and CXCR4 impairing their HIV coreceptor activity. Blood 2012, 119:4908-4918.
107. Tommasino M. The human papillomavirus family and its role in carcinogenesis. Semin. Cancer Biol. 2013.
108. Tschische P., Tadagaki K., Kamal M., Jockers R., Waldhoer M. Heteromerization of human cytomegalovirus encoded chemokine receptors. Biochem. Pharmacol. 2011, 82:610-619.
109. Twizere J.C., Springael J.Y., Boxus M., Burny A., Dequiedt F., Dewulf J.F., Duchateau J., Portetelle D., Urbain P., Van Lint C., Green P.L., Mahieux R., Parmentier M., Willems L., Kettmann R. Human T-cell leukemia virus type-1 Tax oncoprotein regulates G-protein signaling. Blood 2007, 109:1051-1060.
110. Vicenzi E., Lio P., Poli G. The puzzling role of CXCR4 in human immunodeficiency virus infection. Theranostics 2013, 3:18-25.
111. Vignoli M., Furlini G., Re M.C., Ramazzotti E., La Placa M. Modulation of CD4, CXCR-4, and CCR-5 makes human hematopoietic progenitor cell lines infected with human herpesvirus-6 susceptible to human immunodeficiency virus type 1. J. Hematother. Stem Cell Res. 2000, 9:39-45.
112. Vila-Coro A.J., Rodriguez-Frade J.M., Martin De Ana A., Moreno-Ortiz M.C., Martinez A.C., Mellado M. The chemokine SDF-1alpha triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway. FASEB J. 1999, 13:1699-1710.
113. Viswanathan K., Fruh K., DeFilippis V. Viral hijacking of the host ubiquitin system to evade interferon responses. Curr. Opin. Microbiol. 2010, 13:517-523.
114. Vomaske J., Melnychuk R.M., Smith P.P., Powell J., Hall L., DeFilippis V., Fruh K., Smit M., Schlaepfer D.D., Nelson J.A., Streblow D.N. Differential ligand binding to a human cytomegalovirus chemokine receptor determines cell type-specific motility. PLoS Pathog. 2009, 5:e1000304.
115. Warner J.A., Zwezdaryk K.J., Day B., Sullivan D.E., Pridjian G., Morris C.A. Human cytomegalovirus infection inhibits CXCL12- mediated migration and invasion of human extravillous cytotrophoblasts. Virol. J. 2012, 9:255.
116. Weitzenfeld P., Ben-Baruch A. The chemokine system, and its CCR5 and CXCR4 receptors, as potential targets for personalized therapy in cancer. Cancer Lett. 2013.
117. Xu J., Deng X., Tang M., Li L., Xiao L., Yang L., Zhong J., Bode A.M., Dong Z., Tao Y., Cao Y. Tyrosylprotein sulfotransferase-1 and tyrosine sulfation of chemokine receptor 4 are induced by Epstein-Barr virus encoded latent membrane protein 1 and associated with the metastatic potential of human nasopharyngeal carcinoma. PloS ONE 2013, 8:e56114.
118. Yamanishi K. Human herpesvirus 6. Microbiol. Immunol. 1992, 36:551-561.
119. Yasukawa M., Hasegawa A., Sakai I., Ohminami H., Arai J., Kaneko S., Yakushijin Y., Maeyama K., Nakashima H., Arakaki R., Fujita S. Down-regulation of CXCR4 by human herpesvirus 6 (HHV-6) and HHV-7. J. Immunol. 1999, 162:5417-5422.
120. Zhang Y., Foudi A., Geay J.F., Berthebaud M., Buet D., Jarrier P., Jalil A., Vainchenker W., Louache F. Intracellular localization and constitutive endocytosis of CXCR4 in human CD34+ hematopoietic progenitor cells. Stem Cells 2004, 22:1015-1029.
121. Zhao C., Lu X., Bu X., Zhang N., Wang W. Involvement of tumor necrosis factor-alpha in the upregulation of CXCR4 expression in gastric cancer induced by Helicobacter pylori. BMC Cancer 2010, 10:419.
122. Zhou L., Bohn L.M. Functional selectivity of GPCR signaling in animals. Curr. Opin. Cell Biol. 2014, 27C:102-108.
123. Zlotnik A., Yoshie O., Nomiyama H. The chemokine and chemokine receptor superfamilies and their molecular evolution. Genome Biol. 2006, 7:243.
124. Zou Y.R., Kottmann A.H., Kuroda M., Taniuchi I., Littman D.R. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 1998, 393:595-599.